Balyasny Asset Management L.P. Buys Shares of 15,206 Simulations Plus, Inc. (NASDAQ:SLP)

Balyasny Asset Management L.P. purchased a new stake in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 15,206 shares of the technology company's stock, valued at approximately $424,000. Balyasny Asset Management L.P. owned 0.08% of Simulations Plus as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC increased its position in shares of Simulations Plus by 15.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company's stock worth $62,090,000 after purchasing an additional 290,414 shares in the last quarter. Royce & Associates LP grew its holdings in shares of Simulations Plus by 56.6% during the fourth quarter. Royce & Associates LP now owns 371,797 shares of the technology company's stock worth $10,369,000 after buying an additional 134,381 shares in the last quarter. Nicholas Company Inc. purchased a new stake in shares of Simulations Plus during the fourth quarter worth $3,418,000. Kennedy Capital Management LLC raised its position in shares of Simulations Plus by 59.4% in the fourth quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company's stock valued at $8,068,000 after buying an additional 107,766 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of Simulations Plus by 210.7% in the fourth quarter. JPMorgan Chase & Co. now owns 147,154 shares of the technology company's stock worth $4,104,000 after buying an additional 99,789 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on SLP. KeyCorp upped their price objective on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th. StockNews.com upgraded Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Two investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $50.00.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the transaction, the director now owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. This represents a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 19.40% of the stock is owned by insiders.

Simulations Plus Trading Up 0.4%

SLP stock traded up $0.13 during trading on Thursday, reaching $31.83. 32,210 shares of the stock were exchanged, compared to its average volume of 213,772. The firm has a market capitalization of $640.03 million, a price-to-earnings ratio of 79.39 and a beta of 1.10. The business has a 50 day moving average price of $29.39 and a 200-day moving average price of $30.33. Simulations Plus, Inc. has a 1 year low of $23.01 and a 1 year high of $50.98.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business had revenue of $22.43 million during the quarter, compared to the consensus estimate of $21.93 million. During the same quarter last year, the firm earned $0.20 EPS. The business's revenue was up 22.5% compared to the same quarter last year. On average, research analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.